Ropes & Gray Counsels Arcadia Consumer Healthcare in the Acquisition of the U.S. Rights to Sanofi’s Kaopectate®

In The News
March 25, 2020

Ropes & Gray counseled Arcadia Consumer Healthcare, a portfolio company of Avista Capital Partners, in its purchase of the U.S. rights to the Kaopectate® brand from Sanofi. The transaction was announced on March 20. Terms of the transaction weren’t disclosed. The press release is here. 

Arcadia Consumer Healthcare, Inc., formerly Kramer Laboratories, Inc., is a recognized leader in the consumer healthcare market for over-the-counter medicines. For over 35 years, the company has delivered innovative healthcare products to help consumers self-treat their everyday problems. Avista Capital Partners is a leading middle-market healthcare-focused private equity firm. 

The Ropes & Gray team that advised Arcadia Consumer Healthcare was led by private equity partners David Blittner and Bob Rivollier, and included Arkadiusz Maczka (all of New York).